Some antidepressants interfere with breast cancer treatment, reports the Harvard Mental Health Letter
Three antidepressants commonly used to treat the anxiety and depression that accompany a diagnosis of breast cancer negate the protective effect of tamoxifen, a drug widely used to fight breast cancer, reports the June issue of the Harvard Mental Health Letter.
The most common type of breast cancer is fueled by the female hormone estrogen. Tamoxifen has become a standard treatment for women with such estrogen-positive breast cancer because it reduces the chances that breast cancer will recur and improves survival. Three antidepressants—paroxetine (Paxil), fluoxetine (Prozac), and bupropion (Wellbutrin)—should be avoided while taking tamoxifen because they may interfere with its anticancer effects. These antidepressants are also used to treat hot flashes and aid with smoking cessation.
To continue reading this article, you must log in.
Source matters. Subscribe to HarvardHealthOnline+ FREE for 30 days for unlimited access to the site – where all content is reviewed by an HMS physician or faculty expert.
With HHO+ you get these exclusive benefits:
- Unlimited access to all Harvard Health Online content
- 4 expertly curated newsletters delivered monthly
- Customized website experience aligned to your health goals
- In-depth health guides on topics like sleep, exercise, and more
- Interactive features like videos and quizzes
- Members-only access to exclusive articles and resources
SPECIAL OFFER! UNLOCK EXPERT ACCESS for 30 days FREE!
Already a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.